Skip to site menu Skip to page content

Daily Newsletter

02 December 2024

Daily Newsletter

02 December 2024

Advances in AI-driven cardiac devices pave way for personalised heart care 

The global market for cardiovascular devices is projected to grow rapidly, with estimates of $140 billion by 2033.

GlobalData Healthcare November 29 2024

Recent research highlights groundbreaking progress in the development of adaptive cardiac monitoring and therapeutic devices, showcasing the transformative potential of AI in cardiovascular care.

The devices, which integrate AI-driven algorithms, represent a shift toward more personalised and real-time heart health management. 

Adaptive cardiac devices differ from traditional pacemakers and monitors by dynamically adjusting to a patient’s condition. AI-powered implants can analyse fluctuations in heart rhythms and optimise therapy delivery based on real-time data. This approach ensures precise treatment tailored to the patient’s evolving needs, providing 24/7 care and significantly improving outcomes for conditions such as arrhythmias or heart failure. 

Wearable cardiac monitors are becoming mainstream

The global market for cardiovascular devices is projected to grow rapidly, with estimates suggesting a valuation of $84.8 billion in 2023 and a compound annual growth rate (CAGR) of 5.2% reaching $140 billion by 2033, according to industry data. This surge reflects the increasing adoption of advanced cardiac technologies, including AI-enhanced diagnostics and therapeutic tools. 

The integration of AI in medical devices extends beyond the implantable realm. Wearable cardiac monitors, such as smartwatches equipped with electrocardiogram (ECG) functionality, are becoming mainstream. These devices enable continuous, non-invasive tracking of heart health, empowering patients and physicians with actionable insights outside traditional clinical settings. Combined with AI-enhanced therapeutic devices, this creates a cohesive ecosystem for managing cardiovascular diseases. 

As the adoption of advanced cardiac technologies accelerates, efforts will likely focus on demonstrating their efficacy in clinical trials, optimising their cost-effectiveness and expanding access globally. The future of cardiac care will increasingly hinge on AI’s ability to blend monitoring and therapy, setting a new standard in personalised medicine and improving patient outcomes in one of the most critical areas of healthcare.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close